Skip to main content
SpringerLink
Log in

R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Capper D, Weissert S, Balss J et al (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20:245–254

    Article  CAS  PubMed  Google Scholar 

  2. Dang L, White DW, Gross S et al (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739–744

    Article  CAS  PubMed  Google Scholar 

  3. Ichimura K, Pearson DM, Kocialkowski S et al (2009) IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncol 11:341–347

    Article  CAS  PubMed  Google Scholar 

  4. Metellus P, Coulibaly B, Colin C et al (2010) Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathol 120:719–729

    Article  PubMed  Google Scholar 

  5. Sanson M, Marie Y, Paris S et al (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27:4150–4154

    Article  CAS  PubMed  Google Scholar 

  6. Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29:625–634

    Article  CAS  PubMed  Google Scholar 

  7. Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5:343–354

    Article  CAS  PubMed  Google Scholar 

  8. Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773

    Article  CAS  PubMed  Google Scholar 

  9. Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW, Semenza GL (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88:2606–2618

    Article  CAS  PubMed  Google Scholar 

  10. Zhao S, Lin Y, Xu W et al (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1α. Science 324:261–265

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants to D.Z. from the National Institutes of Health (R01 CA100426 and R21 NS065280-01) and the Musella Foundation.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, New York University School of Medicine, New York, NY, USA

    Susan C. Williams, John G. Golfinos & David Zagzag

  2. Division of Pediatric Hematology/Oncology, Department of Pediatrics, New York University School of Medicine, New York, NY, USA

    Matthias A. Karajannis

  3. Immunohistochemistry Core, New York University School of Medicine, New York, NY, USA

    Luis Chiriboga

  4. Division of Neuropathology, Department of Pathology, New York University School of Medicine, New York, NY, USA

    David Zagzag

  5. Microvascular and Molecular Neuro-oncology Laboratory, New York University School of Medicine, New York, NY, USA

    David Zagzag

  6. New York University Cancer Institute, New York University School of Medicine, New York, NY, USA

    Matthias A. Karajannis, Luis Chiriboga, John G. Golfinos & David Zagzag

  7. New York University Langone Medical Center, New York University School of Medicine, Medical Science Building #130, 550 First Avenue, New York, NY, 10016, USA

    Susan C. Williams, Matthias A. Karajannis, Luis Chiriboga, John G. Golfinos & David Zagzag

  8. Department of Neuropathology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany

    Andreas von Deimling

  9. Clinical Cooperation Unit Neuropathology, German Cancer Research Center, Heidelberg, Germany

    Andreas von Deimling

Authors
  1. Susan C. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthias A. Karajannis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luis Chiriboga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. John G. Golfinos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Andreas von Deimling
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. David Zagzag
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David Zagzag.

Additional information

S. C. Williams and M. A. Karajannis contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Williams, S.C., Karajannis, M.A., Chiriboga, L. et al. R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma. Acta Neuropathol 121, 279–281 (2011). https://doi.org/10.1007/s00401-010-0790-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-010-0790-y

Keywords

Search

Navigation